BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20091913)

  • 1. Adsorption behavior of a surfactant and a monoclonal antibody to sterilizing-grade filters.
    Mahler HC; Huber F; Kishore RS; Reindl J; Rückert P; Müller R
    J Pharm Sci; 2010 Jun; 99(6):2620-7. PubMed ID: 20091913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterile Filtration of Highly Concentrated Protein Formulations: Impact of Protein Concentration, Formulation Composition, and Filter Material.
    Allmendinger A; Mueller R; Huwyler J; Mahler HC; Fischer S
    J Pharm Sci; 2015 Oct; 104(10):3319-29. PubMed ID: 26149748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding adsorption behavior of Polysorbate-20 to sterile filters in therapeutic proteins final filtration process.
    Ren J; Zhang Y; Wang C
    Biotechnol Prog; 2024; 40(2):e3401. PubMed ID: 37987143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques.
    Mahler HC; Printz M; Kopf R; Schuller R; Müller R
    J Pharm Sci; 2008 Feb; 97(2):764-74. PubMed ID: 17688279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of membrane filters used in biopharmaceutical processes on the concentration and composition of polysorbate 20.
    Lei M; Sugahara J; Hewitt D; Beane D; Jayakar R; Cornell C; Skidmore K; Kao YH; Ji J
    Biotechnol Prog; 2013; 29(6):1503-11. PubMed ID: 24124005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorption of polysorbate 20 and proteins on hydrophobic polystyrene surfaces studied by neutron reflectometry.
    Zhang Z; Orski S; Woys AM; Yuan G; Zarraga IE; Wagner NJ; Liu Y
    Colloids Surf B Biointerfaces; 2018 Aug; 168():94-102. PubMed ID: 29724643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive adsorption of monoclonal antibodies and nonionic surfactants at solid hydrophobic surfaces.
    Kapp SJ; Larsson I; Van De Weert M; Cárdenas M; Jorgensen L
    J Pharm Sci; 2015 Feb; 104(2):593-601. PubMed ID: 25446557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.
    Gerhardt A; Mcumber AC; Nguyen BH; Lewus R; Schwartz DK; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 Dec; 104(12):4056-4064. PubMed ID: 26413998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material.
    Siska CC; Pierini CJ; Lau HR; Latypov RF; Fesinmeyer RM; Litowski JR
    J Pharm Sci; 2015 Feb; 104(2):447-56. PubMed ID: 25196966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant Protection Efficacy at Surfaces Varies with the Nature of Hydrophobic Materials.
    Lefebvre G; Maze A; Alvarez-Palencia Jimenez R; Bruckert F; Filipe V; Huille S; Weidenhaupt M
    Pharm Res; 2021 Dec; 38(12):2157-2166. PubMed ID: 34904200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of extractables/leachables from filters on stability of protein formulations.
    Huang M; Horwitz TS; Zweiben C; Singh SK
    J Pharm Sci; 2011 Nov; 100(11):4617-30. PubMed ID: 21695696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous surface self-assembly in protein-surfactant mixtures: interactions between hydrophobin and ethoxylated polysorbate surfactants.
    Tucker IM; Petkov JT; Penfold J; Thomas RK; Li P; Cox AR; Hedges N; Webster JR
    J Phys Chem B; 2014 May; 118(18):4867-75. PubMed ID: 24738908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface activity of a monoclonal antibody.
    Mahler HC; Senner F; Maeder K; Mueller R
    J Pharm Sci; 2009 Dec; 98(12):4525-33. PubMed ID: 19655376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution.
    Escobar ELN; Griffin VP; Dhar P
    Mol Pharm; 2024 Mar; 21(3):1490-1500. PubMed ID: 38385557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations.
    Kannan A; Shieh IC; Fuller GG
    J Colloid Interface Sci; 2019 Aug; 550():128-138. PubMed ID: 31055138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.
    Patapoff TW; Esue O
    Pharm Dev Technol; 2009; 14(6):659-64. PubMed ID: 19883255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of preservative adsorption onto nylon membrane filters.
    Guilfoyle DE; Roos R; Carito SL
    J Parenter Sci Technol; 1990; 44(6):314-9. PubMed ID: 2277319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology.
    Horiuchi S; Winter G
    Eur J Pharm Biopharm; 2015 May; 92():8-14. PubMed ID: 25684280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Polysorbate 80 Grade on the Interfacial Properties and Interfacial Stress Induced Subvisible Particle Formation in Monoclonal Antibodies.
    Vaclaw C; Merritt K; Pringle V; Whitaker N; Gokhale M; Carvalho T; Pan D; Liu Z; Bindra D; Khossravi M; Bolgar M; Volkin DB; Ogunyankin MO; Dhar P
    J Pharm Sci; 2021 Feb; 110(2):746-759. PubMed ID: 32987092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.